Partner With Us

Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the limited partnership opportunities available for the 2024 event,
please get in touch at

Share your solutions with the top drug developers within the innate immune agonist space and meet your business objectives for the next meeting in 2024

Partners met in person, for the first time ever, at the STING & TLR Targeting Therapies Summit 2023, where they showcased their expertise to over 100 senior leaders in the field of innate targeting therapies. This event was the perfect opportunity to form long-lasting connections with experts in the space who share a common goal of accelerating progress and overcoming delivery, patient selection and toxicity challenges.

As the only meeting exclusively focused on advancing the development of innate targeting therapies, this was a must-attend event for anyone in the field.

Get in touch today to learn more about opportunities in 2024.

Benefits of Partnering:

STING & TLR Thought Leader

Position Yourself as an Industry Thought Leader

Now is your chance
to get in front of
your target key
decision makers
in the market and
demonstrate your
expertise through
chairing or through
panel discussions

STING & TLR Brand Awareness

Raise Brand Awareness

Increase your reach
and exposure
to new clients,
customers, and
businesses through
unique branding
pre and postconference

STING & TLR Network

Meet & Network with Industry Pioneers

With a room full of
drug developers
looking to see how
they can produce
the safe and
efficacious STING & TLR Targeting Therapies,
fill your pipeline
with new leads for
2023 through 1-2-1 virtual meetings and virtual networking

STING & TLR Collaborations

Generate Commercial Collaborations

Make sure your
hottest prospects
are in the ‘room’
and part of the
discussion, by
having a wish-list
of your choice
contacted in
advance of the

STING & TLR Market Intelligence

Benefit from Market Intelligence

Discover what
solutions and
services companies
will be investing
into innate immune
therapies to enable you to match your solutions